Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of peripheral T cell lymphoma

Treatment of peripheral T cell lymphoma

US Patent 11999784 · Granted Jun 4, 2024

Estimated economic value: $209,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

NKp46 binding agents2025
Compound that specifically binds to KIR3DL2 for use in the treatment of peripher2024
Compound that specifically binds to KIR3DL2 for use in the treatment of peripher2024
Compound that specifically binds to KIR3DL2 for use in the treatment of peripher2024
Treatment regimens using anti-NKG2A antibodies2024
Treatment with anti-KIR3DL2 agents2024
KIR3DL2 binding agents2024
Neutralization of inhibitory pathways in lymphocytes2023
NKp46 binding agents2022
Treatment of cancers using anti-NKG2A agents2022
Compound that specifically binds to KIR3DL2 for use in the treatment of peripher2021
Compound that specifically binds to KIR3DL2 for use in the treatment of peripher2021